PhRMA Perspectives on Drug Substance Regulatory Filing Issues

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-02-02-2003
Volume 27
Issue 2

The PhRMA API Technical Group examines topics concerning active pharmaceutical ingredient development and manufacture and makes recommendations for regulatory guidance.

Recent Videos
Drug Digest: Strategic Partnerships
Michelle Bridenbaker from Unbiased Science discusses her thoughts on the key industry from 2024 and those she anticipates will impact the industry in 2025 and beyond.
Related Content